Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination.

MLA

Velentgas, Priscilla, et al. “Risk of Guillain-Barré Syndrome after Meningococcal Conjugate Vaccination.” Pharmacoepidemiology and Drug Safety, vol. 21, no. 12, Dec. 2012, pp. 1350–58. EBSCOhost, https://doi.org/10.1002/pds.3321.

APA

Velentgas, P., Amato, A. A., Bohn, R. L., Chan, K. A., Cochrane, T., Funch, D. P., Dashevsky, I., Duddy, A. L., Gladowski, P., Greenberg, S. A., Kramer, J. M., McMahill-Walraven, C., Nakasato, C., Spettell, C. M., Syat, B. L., Wahl, P. M., Walker, A. M., Zhang, F., Brown, J. S., & Platt, R. (2012). Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination. Pharmacoepidemiology and Drug Safety, 21(12), 1350–1358. https://doi.org/10.1002/pds.3321

Chicago

Velentgas, Priscilla, Anthony A Amato, Rhonda L Bohn, K Arnold Chan, Thomas Cochrane, Donnie P Funch, Inna Dashevsky, et al. 2012. “Risk of Guillain-Barré Syndrome after Meningococcal Conjugate Vaccination.” Pharmacoepidemiology and Drug Safety 21 (12): 1350–58. doi:10.1002/pds.3321.